Posted: Sat Dec 12, 2009 6:01 am
I agree, my donations are now going to the MSAA!
Welcome to This is MS, the leading forum for Multiple Sclerosis research and support. Join our friendly community of patients, caregivers, and researchers celebrating over 20 years of delivering hope through knowledge.
https://www.thisisms.com/forum/
Yeah I think "100%" should be eliminated from most discussions when it comes to this. Some of the cases (and I believe the one you mention is one of them) present as atypical, and questionable as to a strict "MS" diagnosis in the first place. This is precisely what raises eyebrows in the scientific world at large, especially with a disease as difficult to ACCURATELY diagnose as MS. By the time you get up into the many hundreds and thousands of subjects, there WILL be people in there with clinically definite MS who were mis-diagnosed, and won't have CCSVI. Marc has pointed us towards this astutely and is absolutely correct in that assessment. Now if we have a smaller subset of patients, of course the possibilities of batting 1.000 increase greatly, but small numbers are of no consequence to the scientific world.ozarkcanoer wrote:Billmeik said :
"In 100% of patients the model was correct.
To say 'they're only at 50% is sort of wrong'. Also they don't mention the small replicating studies at buffalo and stanford that got 100%"
I hate to be a nitpicker since I am as much of a CCSVI as anyone, but how do you know that Buffalo and Stanford got 100% correlation between MS and CCSVI ? There was one person who posted here who reported that she cried all the way home from Stanford because her MRI/MRVs showed nothing wrong.
ozarkcanoer
I am a little confused - are you referring to Zamboni's 65 MS patients who were treated with the endovascular balloon procedure? You are correct - those 65 patients had a stenosis, but that was one of Zamboni's selection criteria: this is from Burk's articleIn 100% of patients the model was correct.
To say 'they're only at 50% is sort of wrong'. Also they don't mention the small replicating studies at buffalo and stanford that got 100%
The next statement by Billmeik- "To say they're only at 50% is sort of wrong" Which reference to 50% are you questioning?The 65 participants included 35 individuals with relapsing-remitting MS (RRMS), 20 with secondary-progressive MS (SPMS), and 10 with primary-progressive MS (PPMS). A number of criteria were used to select the patients, including a confirmed diagnosis of MS as well as CCSVI, normal kidney function, and RRMS patients who were taking FDA-approved disease-modifying treatments.